These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus. Hanto DW, Frizzera G, Purtilo DT, Sakamoto K, Sullivan JL, Saemundsen AK, Klein G, Simmons RL, Najarian JS. Cancer Res; 1981 Nov; 41(11 Pt 1):4253-61. PubMed ID: 6272971 [Abstract] [Full Text] [Related]
4. Detection of Epstein-Barr virus genomes by in situ DNA hybridization with a terminally biotin-labeled synthetic oligonucleotide probe from the EBV Not I and Pst I tandem repeat regions. Montone KT, Budgeon LR, Brigati DJ. Mod Pathol; 1990 Jan; 3(1):89-96. PubMed ID: 2155420 [Abstract] [Full Text] [Related]
5. Posttransplant lymphoproliferative disorder in a kidney-pancreas transplanted recipient: simultaneous development of clonal lymphoid B-cell proliferation of host and donor origin. Heyny-von Haussen R, Klingel K, Riegel W, Kandolf R, Mall G. Am J Surg Pathol; 2006 Jul; 30(7):900-5. PubMed ID: 16819335 [Abstract] [Full Text] [Related]
6. EBV-associated B- and T-cell posttransplant lymphoproliferative disorders following primary EBV infection in a kidney transplant recipient. Yin CC, Medeiros LJ, Abruzzo LV, Jones D, Farhood AI, Thomazy VA. Am J Clin Pathol; 2005 Feb; 123(2):222-8. PubMed ID: 15842046 [Abstract] [Full Text] [Related]
7. Posttransplant lymphoproliferative disorder in pediatric bone marrow transplant recipients: disseminated disease of donor origin demonstrated by fluorescence in situ hybridization. Lones MA, Lopez-Terrada D, Shintaku IP, Rosenthal J, Said JW. Arch Pathol Lab Med; 1998 Aug; 122(8):708-14. PubMed ID: 9701332 [Abstract] [Full Text] [Related]
8. Epstein-Barr virus detection in sequential biopsies from patients with a posttransplant lymphoproliferative disorder. Lager DJ, Burgart LJ, Slagel DD. Mod Pathol; 1993 Jan; 6(1):42-7. PubMed ID: 8381232 [Abstract] [Full Text] [Related]
9. Donor origin of posttransplant lymphoproliferative disorder localized to a liver allograft: demonstration by fluorescence in situ hybridization. Lones MA, Lopez-Terrada D, Weiss LM, Shintaku IP, Said JW. Arch Pathol Lab Med; 1997 Jul; 121(7):701-6. PubMed ID: 9240905 [Abstract] [Full Text] [Related]
10. Plasmacytic hyperplasia in age-related Epstein-Barr virus-associated lymphoproliferative disorders: a report of two cases. Kojima M, Morita Y, Nakamura N, Shimizu K, Murayama K, Nakamura S. Pathol Res Pract; 2008 Jul; 204(4):267-72. PubMed ID: 18187262 [Abstract] [Full Text] [Related]
11. Patterns of Epstein-Barr virus latent and replicative gene expression in Epstein-Barr virus B cell lymphoproliferative disorders after organ transplantation. Rea D, Fourcade C, Leblond V, Rowe M, Joab I, Edelman L, Bitker MO, Gandjbakhch I, Suberbielle C, Farcet JP. Transplantation; 1994 Aug 15; 58(3):317-24. PubMed ID: 8053055 [Abstract] [Full Text] [Related]
12. Post-transplantation lymphoproliferative disorders in Mexico: an aggressive clonal disease associated with Epstein-Barr virus type A. Quintanilla-Martínez L, Lome-Maldonado C, Schwarzmann F, Gredler E, Reyes E, Angeles-Angeles A, Fend F. Mod Pathol; 1998 Feb 15; 11(2):200-8. PubMed ID: 9504692 [Abstract] [Full Text] [Related]
16. Epstein-Barr virus-associated lymphoproliferative disease in a heart-lung allograft. Demonstration of host origin by restriction fragment-length polymorphism analysis. Randhawa PS, Yousem SA. Transplantation; 1990 Jan 15; 49(1):126-30. PubMed ID: 1967858 [Abstract] [Full Text] [Related]
17. HHV-8+, EBV+ multicentric plasmablastic microlymphoma in an HIV+ Man: the spectrum of HHV-8+ lymphoproliferative disorders expands. Seliem RM, Griffith RC, Harris NL, Beheshti J, Schiffman FJ, Longtine J, Kutok J, Ferry JA. Am J Surg Pathol; 2007 Sep 15; 31(9):1439-45. PubMed ID: 17721201 [Abstract] [Full Text] [Related]
18. Epstein-Barr virus (EBV)-associated post-transplantation lymphoproliferative disorder simultaneously affecting both B and T cells after allogeneic bone marrow transplantation. Chuhjo T, Yachie A, Kanegane H, Kimura H, Shiobara S, Nakao S. Am J Hematol; 2003 Apr 15; 72(4):255-8. PubMed ID: 12666136 [Abstract] [Full Text] [Related]